Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site

被引:97
|
作者
Durdagi, Serdar [2 ]
Senturk, Murat [1 ]
Ekinci, Deniz [3 ,4 ]
Balaydin, Halis Turker [5 ]
Goksu, Suleyman [6 ]
Kufrevioglu, O. Irfan [6 ]
Innocenti, Alessio [7 ]
Scozzafava, Andrea [7 ]
Supuran, Claudiu T. [7 ]
机构
[1] Ibrahim Cecen Univ Agri, Sci & Art Fac, Dept Chem, TR-04100 Agri, Turkey
[2] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada
[3] Ondokuz Mayis Univ, Fac Agr, Dept Agr Biotechnol, TR-55139 Samsun, Turkey
[4] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
[5] Artvin Coruh Univ, Fac Educ, TR-08100 Artvin, Turkey
[6] Ataturk Univ, Fac Sci, Dept Chem, TR-25240 Erzurum, Turkey
[7] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
关键词
Carbonic anhydrase; Phenol; Sulfonamide; Dimethoxy-benzene; Phenolic acid; Docking; Enzyme inhibition; ISOZYME-II; CRYSTAL-STRUCTURE; SALICYLIC-ACID; ACTIVATORS; SULFONAMIDES; COUMARINS; DESIGN; AGENTS; ADDUCT; SERIES;
D O I
10.1016/j.bmc.2011.01.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1381 / 1389
页数:9
相关论文
共 41 条
  • [21] Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors
    Lolak, Nabih
    Akocak, Suleyman
    Bua, Silvia
    Sanku, Rajesh K. K.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (08) : 1588 - 1594
  • [22] Vanillin enones as selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. The out of the active site pocket for the design of selective inhibitors?
    Riafrecha, Leonardo E.
    Le Pors, Macarena S.
    Lavecchia, Martin J.
    Bua, Silvia
    Supuran, Claudiu T.
    Colinas, Pedro A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 2118 - 2127
  • [23] An inhibitor-like binding mode of a carbonic anhydrase activator within the active site of isoform II
    Dave, Khyati
    Ilies, Marc A.
    Scozzafava, Andrea
    Temperini, Claudia
    Vullo, Daniela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2764 - 2768
  • [24] Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties
    Colinas, Pedro A.
    Bravo, Rodolfo D.
    Vullo, Daniela
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5086 - 5090
  • [25] QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII
    Tarko, Laszlo
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1404 - 1409
  • [26] Carbonic anhydrase inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety
    Sethi, Kalyan K.
    Vullo, Daniella
    Verma, Saurabh M.
    Tanc, Muhammet
    Carta, Fabrizio
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (19) : 5973 - 5982
  • [27] Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies
    Carta, Fabrizio
    Garaj, Vladimir
    Maresca, Alfonso
    Wagner, Jason
    Avvaru, Balendu Sankara
    Robbins, Arthur H.
    Scozzafava, Andrea
    McKenna, Robert
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (10) : 3105 - 3119
  • [28] 4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies
    Nada, Hossam
    Elkamhawy, Ahmed
    Abdellattif, Magda H.
    Angeli, Andrea
    Lee, Chang Hoon
    Supuran, Claudiu T.
    Lee, Kyeong
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 994 - 1004
  • [29] Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II
    Carta, Fabrizio
    Maresca, Alfonso
    Scozzafava, Andrea
    Vullo, Daniela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7093 - 7099
  • [30] New 7-hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies
    Maddipatla, Sarvan
    Bakchi, Bulti
    Shinde, Mayura Anil
    Bonardi, Alessandro
    Raman, Preethi K.
    Bhalerao, Harshada Anil
    Singampalli, Anuradha
    Nanduri, Srinivas
    Godugu, Chandraiah
    Sonti, Rajesh
    Supuran, Claudiu T.
    Yaddanapudi, Venkata Madhavi
    ARCHIV DER PHARMAZIE, 2025, 358 (01)